In particular, the expression levels of MLL3 and SET1A were enhanced in the cancer tissues of patients with tamoxifen-resistant breast cancer, which may lead to the ERα-dependent proliferation of these cells (Figs. 1 and 2). This evidence concerns the gene ESR1 and breast carcinoma.